Minoxidil/Finasteride - Jina Pharmaceuticals/Intas PharmaceuticalsAlternative Names: Lipid based MorrF; MorrF
Latest Information Update: 02 Sep 2015
At a glance
- Originator Intas Pharmaceuticals; Jina Pharmaceuticals
- Class Antiandrogens; Peripheral vasodilators; Small molecules
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors; Potassium channel agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Alopecia
Most Recent Events
- 02 Sep 2015 Launched for Alopecia in India (Topical) before September 2015
- 02 Sep 2015 Intas Pharmaceuticals and Jina Pharmaceuticals collaborated in the development of Nanoaqualip™ technology